Prevalence of Anemia among Adults with Newly Diagnosed HIV/AIDS in China

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Shen, Yinzhong ^a   Wang, Zhenyan ^a   Lu, Hongzhou ^a   Wang, Jiangrong ^a   Chen, Jun ^a   Liu, Li ^a   Zhang, Renfang ^a   Zheng, Yufang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CHINA; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNICITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; CD4 LYMPHOCYTE COUNT; CHINA; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84884221082     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073807     Document Type: Article

References (22)

1. Zon LI, Arkin C, Groopman JE, (1987) Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol. 66: 251-256.
2. Erhabor O, Ejele OA, Nwauche CA, Buseri FI, (2005) Some haematological parameters in human immunodeficiency virus (HIV) infected Africans: the Nigerian perspective. Niger J Med. 14: 33-38.
3. Bello JL, Burgaleta C, Magallon M, Herruzo R, Villar JM, (1990) Hematological abnormalities in hemophilic patients with human immunodeficiency virus infection. Am J Hematol. 33: 230-233.
4. Meidani M, Rezaei F, Maracy MR, Avijgan M, Tayeri K, (2012) Prevalence, severity, and related factors of anemia in HIV/AIDS patients. J Res Med Sci. 17: 138-142.
5. Munyazesa E, Emile I, Mutimura E, Hoover DR, Shi Q, et al. (2012) Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study. BMJ Open. 2. pii: e001600. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533001. Accessed 21 March 2013.
6. Wills TS, Nadler JP, Somboonwit C, Vincent A, Leitz G, et al. (2004) Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort. AIDS Read. 14: 305-310, 313-315.
7. Mildvan D, Creagh T, Leitz G, (2007) Anemia Prevalence Study Group (2007) Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study. Curr Med Res Opin. 23: 343-355.
8. Anastos K, Shi Q, French AL, Levine A, Greenblatt RM, et al. (2004) Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 35: 383-392.
9. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW, (1998) Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 91: 301-308.
10. Cleveland RP, Liu YC, (1996) CD4 expression by erythroid precursor cells in human bone marrow. Blood. 87: 2275-2282.
11. Spivak JL, Barnes DC, Fuchs E, Quinn TC, (1989) Serum immunoreactive erythropoietin in HIV-infected patients. JAMA. 261: 3104-3107.
12. Mata-Marín JA, Gaytán-Martínez JE, Martínez-Martínez RE, Arroyo-Anduiza CI, Fuentes-Allen JL, et al. (2010) Risk factors and correlates for anemia in HIV treatment-naïve infected patients: a cross-sectional analytical study. BMC Res Notes. 3: 230. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941498. Accessed 21 March 2013.
13. Omoregie R, Omokaro EU, Palmer O, Ogefere HO, Egbeobauwaye A, et al. (2009) Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria. Tanzan J Health Res. 11: 1-4.
14. Parinitha S, Kulkarni M (2012) Haematological changes in HIV infection with correlation to CD4 cell count. Australas Med J. 5: 157-162. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433730. Accessed 21 February 2013.
15. Subbaraman R, Devaleenal B, Selvamuthu P, Yepthomi T, Solomon SS, et al. (2009) Factors associated with anaemia in HIV-infected individuals in southern India. Int J STD AIDS. 20: 489-492.
16. Mugisha JO, Shafer LA, Van der Paal L, Mayanja BN, Eotu H, et al. (2008) Anaemia in a rural Ugandan HIV cohort: prevalence at enrolment, incidence, diagnosis and associated factors. Trop Med Int Health. 13: 788-794.
17. Belperio PS, Rhew DC, (2004) Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med. 116Suppl 7A: 27S-43S.
18. Semba RD, Shah N, Vlahov D, (2001) Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 26: 315-319.
19. Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, et al. (2004) Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 37: 1245-1252.
20. Moore RD, Forney D, (2002) Anemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 29: 54-57.
21. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, et al. (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 317: 192-197.
22. Gonzalez L, Seley C, Martorano J, Garcia-Moreno I, Troncoso A, (2012) Infections and inequalities: anemia in AIDS, the disadvantages of poverty. Asian Pac J Trop Biomed. 2: 485-488.